Exosome Diagnostic and Therapeutics Market
Market Insights on Exosome Diagnostic and Therapeutics covering sales outlook, demand forecast & up-to-date key trends
Exosomes Diagnostic and Therapeutic Market By Product (Instruments, Software, Reagents & Kits), By Application (Diagnostics and Therapeutics), By End User (Hospitals, Cancer Institutes, Diagnostic Centers and others) and By Region, Forecast 2022-2028
Exosomes Diagnostic and Therapeutic Market Snapshot
[229 Pages Report] The Exosomes Diagnostic and Therapeutic Market is estimated at USD 58.6 million in 2022 and is projected to reach USD 175.4 million by 2028, growing at a CAGR of 20.0% during the forecast period (2022-2028).
Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2021 |
US$ 46.7 Mn |
|
Market Value 2028 |
US$ 175.4 Mn |
|
CAGR 2022-2028 |
20.0% |
|
Market Share of Top 5 Countries |
75.3% |
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
22.28% |
|
H1, 2022 Projected |
20.04% |
|
H1, 2022 Outlook |
19.94% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 234 ↓ |
The global exosome diagnostic and therapeutic market development is conditional, and influenced by regulatory approvals by the EMA, the U.S. FDA, CE and other regulatory authorities, in accordance with impact of macro and industry factors. Key developments in this market include the potential of exosomes as diagnostic biomarkers and in targeted drug delivery for oncology and neurodegenerative disorders.
FMI presents a comparative analysis about the market growth rates and development prospects in the global exosome diagnostic and therapeutic market. As per Future Market Insights’ analysis, the exosome diagnostic and therapeutic market is expected to dip by 234 Basis Point Share (BPS) in H1 2022 period in comparison to H1-2021.
Additionally, the variation between the BPS values observed within the market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 units Major reasons for this fall in BPS are attributed to inefficient exosome separation, characterization difficulties, and lack of high-resolution visualization techniques.
Lack of compiled data to diagnose diseases based on exosomes is another practical clinical limitation to the market. Other market segments are set to perform fairly and attain promising growth prospects in the next half of projection period, however the growth is set to display a slow graduation.
Additionally, there are some beneficial points that impact the industry growth, including studies on exosome biogenesis pathways to inhibit disease derived exosomes and using exosomes as delivery vehicles for therapeutic treatments.
Sales Analysis of Exosomes diagnostic and therapeutic from 2012 to 2021 Vs Market Outlook for 2022 to 2028
The exosomes diagnostic and therapeutic market holds around 1.6% of the overall US$ 2.9 Bn Liquid Biosy market in 2021.
The global exosomes diagnostic and therapeutic market is primarily driven by the rising prevalence of chronic diseases, such as neurodegenerative disorders, cancer, autoimmune diseases, etc., and the subsequent growth of production of drugs and drug delivery technologies with diagnostic assays for such chronic ailments.
The advancements in development of genotype and phenotype-specific drug assays by pharmaceutical manufacturers have further increased focus on development of new drug delivery systems, thus propelling the growth of exosomes diagnostic and therapeutic market.
The potential applications of biomarkers in cancer diagnostics and their role in the development of translational precision medicine is set to invoke the novel uses of exosomes in advanced therapeutic and diagnostic research.
Rising demand for differential tests for diagnosis and screening of chronic diseases and the high therapeutic potential of exosomes in cancer diagnostics is perceived as a key factor in the growth enhancement of exosomes diagnostic and therapeutic market.
Moreover, there resides an urgent need for non-invasive diagnostic tests for certain types of cancers, and the potential applications of exosomes provides a lucrative opportunity of alternative diagnosis, as compared to the presently approved invasive diagnostic methods.
There are few blood tests for diagnosis of prion diseases, such as fatal neurodegenerative infectious disease, which poses a major public health concern, as the disease can spread through transmission of blood. The applications of exosome for diseases associated form of prion protein has vast implications in disease detection, and is thus a contributing factor to the growth of exosomes diagnostic and therapeutic market.
The global exosomes diagnostic and therapeutic market expanded at 18.7% CAGR over the past 9 years from 2012 to 2021. The market is expected to expand at a considerable growth rate over the next six years at a CAGR of close to 20.0%.
What are the Key Opportunities for Exosomes diagnostic and therapeutic Manufacturers?
Because of the cost containment factor in healthcare in majority of mature markets, many hospital-based laboratories are experiencing coercion to provide services with a reduced cost. Since the prevalence of chronic diseases is increasing globally in combination with the rising geriatric population, healthcare facilities are witnessing a rise in patient footfall.
To mitigate the increasing service rate at reduced costs, majority of laboratories have begun to adopt solutions integrated with informatics, thus availing increased productivity within current resource availability.
To further support this approach, manufacturers in the exosomes diagnostic and therapeutic market have managed to uptake an opportunistic approach of providing such healthcare facilities with complementary services and support in terms of diagnostic tests products, thus contributing to the growth of the market over the forecast period.
Additionally, the advent of non-invasive methods of cancer diagnosis through optical analysis and the introduction of biophotonics utilizing field carcinogenesis is set to promote the detection of early precancerous changes in the affected organ.
This provides the key manufacturers with an opportunity to develop non-invasive tests for diagnosis of cancer as well as maintain partnerships with academic institutes to work on development of novel non-invasive diagnostics, thus behaving as a contributing factor for market growth throughout the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Factors Restraining Demand for Exosomes diagnostic and therapeutic?
The factors restraining the growth of exosomes diagnostic and therapeutic market include the lack of standardized purification protocols for a validated panel of exosome, given the list of biomarkers in the field of diagnostics is expanding persistently. Moreover, the lack of validation of revised panel of exosomes is also posing as a restrictive factor for development of exosomes diagnostic and therapeutic market.
Although the exosomes diagnostic and therapeutic market is at a nascent stage of development, the majority of existing products available in the market are based only for research purpose while some reagents and kits available have proprietary laboratory analysis tests applications.
The lack of approved products in exosomes diagnostic and therapeutic market over the globe, thus, stands as a restraint to the growth of the market, despite high-value propositions of molecular diagnostics for cancer. This is due to insufficient cost coverage and high cost associated test procedures of such diagnostic tests on patients with chronic ailments.
Moreover, the development of superior instruments (for instance, the exosome isolation columns and analytical instruments for the laboratory analysis of cancer specimens) requires large monetary investment, which is one of the key factors responsible for hindering the growth of the exosomes diagnostic and therapeutic market.
Exosomes Diagnostic and Therapeutic Market - Country-wise Insights
What Makes the U.S. the Largest Market for Exosomes diagnostic and therapeutic?
The U.S. dominates the North American region with a total market share of nearly 89.1% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The growth of exosomes diagnostic and therapeutic market in this region is driven by advanced healthcare systems, along with increasing funding for research and development in the country.
Why is Germany Considered a Lucrative Segment for Exosomes diagnostic and therapeutic Market in Western Europe?
Germany exhibited a Y-O-Y growth of nearly 26.4% in the Western Europe exosomes diagnostic and therapeutic market in 2021 and is expected to hold a market value share of 48.4% by the end of 2028. The growth is associated with the rapid concentration of research activities in the applications of exosomes for accessing therapeutic effects of stem cells in the country. This growth was driven by the rising incidence of cancer in the country, and the demand for advanced diagnostic assays for the same.
What Makes China an Emerging Country for Exosomes diagnostic and therapeutic Market?
China holds 42.6% share in the APEJ market in 2021, and is projected to grow at a lucrative rate during the forecast period. The growth of the exosomes diagnostic and therapeutic market in the country is attributed to the rise of clinically studied and observed applications of exosomes as smart nano-platforms for diagnosis and therapy in the country.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Exosomes Diagnostic and Therapeutic Market - Category-wise Insights
Which Exosomes diagnostic and therapeutic Product is Driving Market Growth?
Reagents and kits project a lucrative growth at a CAGR of 23.8% till the end of the forecast period, with the current market share of around 56.0% in 2021. This dominant market value is associated with the rising research and development activities in non-invasive diagnostic assays due to increasing clinical studies, proving the efficiency of use of exosomes in detection and diagnosis of chronic diseases, primarily cancer.
Which Application of Exosomes diagnostic and therapeutic is considered to be Widely Adopted?
Diagnostic applications are largely adopted in the exosomes diagnostic and therapeutic market and hold a revenue share of 71.1% in 2021 and are projected to hold a share over the forecast period with the estimation being 69.4%. The reduced value trend is associated with the development of therapeutic agents through clinical evaluations assisted by using novel exosome biomarkers in disease detection.
Which End User Shows Higher Implementation in Exosomes diagnostic and therapeutic market?
Diagnostic centers hold current global exosomes diagnostic and therapeutic market value share of 35.7% in 2021, and are projected to achieve an estimate market share value of 44.8% by the end of the forecast period. With new product launches by key manufacturers and the introduction of novel diagnostic assay kits, there have increased access to non-invasive and efficient methods for disease detection and diagnosis. Thus, giving a nudge to diagnostic centers for greater value in terms of global market share throughout the forecast period.
Exosomes Diagnostic and Therapeutic Market - Competitive Landscape
Key players in the exosomes diagnostic and therapeutic market utilize strategies involving management of their manufacturing operations through countries which offer lower manufacturing costs, development of novel diagnostic tests for diseases such as neurodegenerative disorders like Alzheimer’s, and acquisition, development and monetization of mature clinical-stage breakthrough technologies.
- In April 2021, Thermo Fisher Scientific launched the Thermo Scientific KingFisher Apex Purification System, a high-throughput sample purification instrument designed for scientists who need to automate the extraction of DNA, RNA, proteins and cells from an array of sample types. The system aids in simplifying and automating the sample preparation workflow to help improve research productivity and drive new discovery, especially for those working with high-value samples such as circulating tumor cells, T-cells and exosomes.
- In March 2021, Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, completed its clinical validation of an in vitro diagnostic (IVD) version of the ExoDx™ Prostate test (EPI) kit enabling self-certification as CE-IVD as of March 22, 2021.
Similarly, recent developments related to companies manufacturing exosomes diagnostic and therapeutic services and technologies have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope as per Exosomes diagnostic and therapeutic Industry Analysis
|
Attribute |
Details |
|
Forecast Period |
2022-2028 |
|
Historical Data Available for |
2012-2021 |
|
Exosomes Diagnostic and Therapeutic Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle East and Africa |
|
Exosomes Diagnostic and Therapeutic Market Key Countries Covered |
US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, India, ASEAN, Australia, New Zealand, South Africa and GCC Countries |
|
Exosomes Diagnostic and Therapeutic Market Key Market Segments Covered |
Product Type, Application, End User and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Market Segments Covered in Exosomes diagnostic and therapeutic Market Research
By Product :
- Instruments
- Software
- Reagents & Kits
By Application :
- Diagnostics
- Therapeutic
By End User :
- Hospitals
- Cancer Institutes
- Diagnostic Centers
- Others
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- APEJ
- Japan
- MEA
Frequently Asked Questions
The global exosomes diagnostic and therapeutic market is worth US$ 46.7 Mn in 2021.
The exosomes diagnostic and therapeutic market is expected to reach US$ 175.4 Mn by the end of 2028, with sales revenue expected to register 20.0% CAGR.
From 2012-2021, the market for exosomes diagnostic and therapeutic expanded at the rate of 18.7%.
The U.S., Germany, China, Canada and U.K. are expected to drive demand for exosomes diagnostic and therapeutic market.
North America is one of the key segments for global exosomes diagnostic and therapeutic market, with the U.S. expected to account over 92.8% of the North American market during the forecast period.
Demand for exosomes diagnostic and therapeutic in Western Europe is expected to register growth of 18.3% over the forecast period.
The U.S., China and Germany are key producers of exosomes diagnostic and therapeutic services.
China exosomes diagnostic and therapeutic market appears to uphold a share of 42.6% in the region of APEJ in 2021. Japan holds a revenue share of 2.6% in 2021 in the global exosomes diagnostic and therapeutic market and is expected to grow at a CAGR of nearly 16.8% during the forecast period.
Table of Content
1. Executive Summary
1.1. Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Global Economic Outlook
3. Exosome Diagnostic and Therapeutic Market View Point Analysis
3.1. Macro-Economic Factors
3.2. Drivers
3.3. Restraints
3.4. Opportunity Analysis
3.5. Trends
4. North America Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028
4.1. Introduction
4.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2021
4.2.1. U.S.
4.2.2. Canada
4.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
4.3.1. U.S.
4.3.2. Canada
4.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2021
4.4.1. Instrument
4.4.2. Software
4.4.3. Reagent
4.5. Market Size (US$ Mn) Forecast By Product, 2022–2028
4.5.1. Instrument
4.5.2. Software
4.5.3. Reagent
4.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2021
4.6.1. Diagnostic
4.6.2. Therapeutic
4.7. Market Size (US$ Mn) Forecast By Application, 2022–2028
4.7.1. Diagnostic
4.7.2. Therapeutic
4.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2021
4.8.1. Hospitals
4.8.2. Cancer Institutes
4.8.3. Diagnostic Centers
4.8.4. Others
4.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
4.9.1. Hospitals
4.9.2. Cancer Institutes
4.9.3. Diagnostic Centers
4.9.4. Others
4.10. Drivers and Restraints: Impact Analysis
4.11. Market Attractiveness Analysis
4.11.1. By Country
4.11.2. By Product
4.11.3. By Application
4.11.4. By End User
5. Latin America Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028
5.1. Introduction
5.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2021
5.2.1. Brazil
5.2.2. Mexico
5.2.3. Rest of Latin America
5.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2021
5.4.1. Instrument
5.4.2. Software
5.4.3. Reagent
5.5. Market Size (US$ Mn) and Volume Forecast By Product , 2022–2028
5.5.1. Instrument
5.5.2. Software
5.5.3. Reagent
5.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2021
5.6.1. Diagnostic
5.6.2. Therapeutic
5.7. Market Size (US$ Mn) Forecast By Application, 2022–2028
5.7.1. Diagnostic
5.7.2. Therapeutic
5.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2021
5.8.1. Hospitals
5.8.2. Cancer Institutes
5.8.3. Diagnostic Centers
5.8.4. Others
5.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
5.9.1. Hospitals
5.9.2. Cancer Institutes
5.9.3. Diagnostic Centers
5.9.4. Others
5.10. Drivers and Restraints: Impact Analysis
5.11. Market Attractiveness Analysis
5.11.1. By Country
5.11.2. By Product
5.11.3. By Application
5.11.4. By End User
6. Western Europe Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2021
6.2.1. Germany
6.2.2. Italy
6.2.3. France
6.2.4. Spain
6.2.5. U.K.
6.2.6. Rest of Western Europe
6.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
6.3.1. Germany
6.3.2. Italy
6.3.3. France
6.3.4. Spain
6.3.5. U.K.
6.3.6. Rest of Western Europe
6.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2021
6.4.1. Instrument
6.4.2. Software
6.4.3. Reagent
6.5. Market Size (US$ Mn) Forecast By Product, 2022–2028
6.5.1. Instrument
6.5.2. Software
6.5.3. Reagent
6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2021
6.6.1. Diagnostic
6.6.2. Therapeutic
6.7. Market Size (US$ Mn) Forecast By Application, 2022–2028
6.7.1. Diagnostic
6.7.2. Therapeutic
6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2021
6.8.1. Hospitals
6.8.2. Cancer Institutes
6.8.3. Diagnostic Centers
6.8.4. Others
6.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
6.9.1. Hospitals
6.9.2. Cancer Institutes
6.9.3. Diagnostic Centers
6.9.4. Others
6.10. Drivers and Restraints: Impact Analysis
6.11. Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Product
6.11.3. By Application
6.11.4. By End User
7. Eastern Europe Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2021
7.2.1. Russia
7.2.2. Poland
7.2.3. Rest of Eastern Europe
7.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2021
7.4.1. Instrument
7.4.2. Software
7.4.3. Reagent
7.5. Market Size (US$ Mn) Forecast By Product, 2022–2028
7.5.1. Instrument
7.5.2. Software
7.5.3. Reagent
7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2021
7.6.1. Diagnostic
7.6.2. Therapeutic
7.7. Market Size (US$ Mn) Forecast By Application, 2022–2028
7.7.1. Diagnostic
7.7.2. Therapeutic
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2021
7.8.1. Hospitals
7.8.2. Cancer Institutes
7.8.3. Diagnostic Centers
7.8.4. Others
7.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
7.9.1. Hospitals
7.9.2. Cancer Institutes
7.9.3. Diagnostic Centers
7.9.4. Others
7.10. Drivers and Restraints: Impact Analysis
7.11. Market Attractiveness Analysis
7.11.1. By Country
7.11.2. By Product
7.11.3. By Application
7.11.4. By End User
8. Asia Pacific excluding Japan Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2021
8.2.1. China
8.2.2. India
8.2.3. Australia and New Zealand
8.2.4. Rest of APEJ
8.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
8.3.1. China
8.3.2. India
8.3.3. Australia and New Zealand
8.3.4. Rest of APEJ
8.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2021
8.4.1. Instrument
8.4.2. Software
8.4.3. Reagent
8.5. Market Size (US$ Mn) Forecast By Product, 2022–2028
8.5.1. Instrument
8.5.2. Software
8.5.3. Reagent
8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2021
8.6.1. Diagnostic
8.6.2. Therapeutic
8.7. Market Size (US$ Mn) Forecast By Application, 2022–2028
8.7.1. Diagnostic
8.7.2. Therapeutic
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2021
8.8.1. Hospitals
8.8.2. Cancer Institutes
8.8.3. Diagnostic Centers
8.8.4. Others
8.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
8.9.1. Hospitals
8.9.2. Cancer Institutes
8.9.3. Diagnostic Centers
8.9.4. Others
8.10. Drivers and Restraints: Impact Analysis
8.11. Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Product
8.11.3. By Application
8.11.4. By End User
9. Japan Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Product, 2012–2021
9.2.1. Instrument
9.2.2. Software
9.2.3. Reagent
9.3. Market Size (US$ Mn) Forecast By Product, 2022–2028
9.3.1. Instrument
9.3.2. Software
9.3.3. Reagent
9.4. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2021
9.4.1. Diagnostic
9.4.2. Therapeutic
9.5. Market Size (US$ Mn) Forecast By Application, 2022–2028
9.5.1. Diagnostic
9.5.2. Therapeutic
9.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2021
9.6.1. Hospitals
9.6.2. Cancer Institutes
9.6.3. Diagnostic Centers
9.6.4. Others
9.7. Market Size (US$ Mn) Forecast By End User, 2022–2028
9.7.1. Hospitals
9.7.2. Cancer Institutes
9.7.3. Diagnostic Centers
9.7.4. Others
9.8. Drivers and Restraints: Impact Analysis
9.9. Market Attractiveness Analysis
9.9.1. By Product
9.9.2. By Application
9.9.3. By End User
10. Middle East & Africa Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2021
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. Rest of MEA
10.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
10.3.1. GCC Countries
10.3.2. South Africa
10.3.3. Rest of MEA
10.4. Historical Market Size (US$ Mn) Analysis By Product, 2012–2021
10.4.1. Instrument
10.4.2. Software
10.4.3. Reagent
10.5. Market Size (US$ Mn) Forecast By Product, 2022–2028
10.5.1. Instrument
10.5.2. Software
10.5.3. Reagent
10.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2021
10.6.1. Diagnostic
10.6.2. Therapeutic
10.7. Market Size (US$ Mn) Forecast By Application, 2022–2028
10.7.1. Diagnostic
10.7.2. Therapeutic
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2021
10.8.1. Hospitals
10.8.2. Cancer Institutes
10.8.3. Diagnostic Centers
10.8.4. Others
10.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
10.9.1. Hospitals
10.9.2. Cancer Institutes
10.9.3. Diagnostic Centers
10.9.4. Others
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Product
10.11.3. By Application
10.11.4. By End User
11. Forecast Factors: Relevance and Impact
12. Forecast Assumptions
13. Competition Landscape
13.1. Competition Dashboard
13.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
13.2.1. Thermo Fisher Scientific, Inc.
13.2.2. NanoSomix, Inc.
13.2.3. NX PHARMAGEN
13.2.4. Malvern Instruments Ltd
13.2.5. Capricor Therapeutic, Inc.
13.2.6. Exosome Diagnostics, Inc.
13.2.7. Exiqon A/S (Aethlon Medical, Inc.)
13.2.8. System Biosciences, Inc.
13.2.9. Aegle Therapeutic
13.2.10. AMS Biotechnology (Europe) Limited
13.2.11. Miltenyi Biotec
13.2.12. Codiak BioSciences Inc.
13.2.13. Lonza Group (HansaBioMed Life Sciences Ltd.)
13.2.14. Exosome Sciences
14. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028, By Region
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2021
14.2.1. North America
14.2.2. Latin America
14.2.3. Western Europe
14.2.4. Eastern Europe
14.2.5. Asia Pacific excluding Japan
14.2.6. Japan
14.2.7. Middle East & Africa
14.3. Market Size (US$ Mn) Forecast By Region, 2022–2028
14.3.1. North America
14.3.2. Latin America
14.3.3. Western Europe
14.3.4. Eastern Europe
14.3.5. Asia Pacific excluding Japan
14.3.6. Japan
14.3.7. Middle East & Africa
14.4. Market Attractiveness Analysis By Region
15. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028, By Product
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) and Volume Analysis By Product , 2012–2021
15.2.1. Instrument
15.2.2. Software
15.2.3. Reagent
15.3. Market Size (US$ Mn) Forecast By Product, 2022–2028
15.3.1. Instrument
15.3.2. Software
15.3.3. Reagent
15.4. Market Attractiveness Analysis By Product
16. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028, By Application
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012–2021
16.2.1. Diagnostic
16.2.2. Therapeutic
16.3. Market Size (US$ Mn) Forecast By Application, 2022–2028
16.3.1. Diagnostic
16.3.2. Therapeutic
16.4. Market Attractiveness Analysis By Application
17. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028, By End User
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2021
17.2.1. Hospitals
17.2.2. Cancer Institutes
17.2.3. Diagnostic Centers
17.2.4. Others
17.3. Market Size (US$ Mn) Forecast By End User, 2022–2028
17.3.1. Hospitals
17.3.2. Cancer Institutes
17.3.3. Diagnostic Centers
17.3.4. Others
17.4. Market Attractiveness Analysis By End User
18. Global Exosome Diagnostic and Therapeutic Market Analysis 2012–2021 and Forecast 2022–2028
18.1. Market Size and Y-o-Y Growth
18.2. Absolute $ Opportunity
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: North Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Country
Table 02: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Product
Table 03: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Application
Table 04: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By End User
Table 05: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Country
Table 06: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Product
Table 07: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Application
Table 08: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By End User
Table 09: Western Europe Exosome Diagnostic And Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Country
Table 10: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Product
Table 11: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Application
Table 12: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By End User
Table 13: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Country
Table 14: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Product
Table 15: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Application
Table 16: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By End User
Table 17: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Country
Table 18: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Product
Table 19: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Application
Table 20: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By End User
Table 21: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Product
Table 22: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Application
Table 23: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By End User
Table 24: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Country
Table 25: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Product
Table 26: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Application
Table 27: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By End User
Table 28: Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Region
Table 29: Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Product
Table 30: Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Application
Table 31: Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Exosome Diagnostic and Therapeutic Market Value Share By Product (2021)
Figure 02: Global Exosome Diagnostic and Therapeutic Market Value Share By Application (2021)
Figure 03: Global Exosome Diagnostic and Therapeutic Market Value Share By End User (2021)
Figure 04: Global Exosome Diagnostic and Therapeutic Market Value Share By Region (2021)
Figure 05: Wheel of Fortune
Figure 06: Role of Exosome in Cell-to-Cell Communication
Figure 07: Global Healthcare Expenditure in US$ Tn (2012–2020)
Figure 08: Applications of Exosome
Figure 09: North America Exosome Diagnostics and Therapeutic Market Share, By Product (2021)
Figure 10: North America Exosome Diagnostics and Therapeutic Market Share, By Application (2021)
Figure 11: North America Exosome Diagnostics and Therapeutic Market Share, By End User (2021)
Figure 12: North America Exosome Diagnostics and Therapeutic Market Share, By Country (2021)
Figure 13: North America Exosome Diagnostics and Therapeutic Market size (US$ Mn) 2021 & 2028
Figure 14: North Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021,
Figure 15: North Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 16: U.S. Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 17: U.S. Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 18: Canada Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 19: Canada Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 20: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Instruments
Figure 21: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Instruments
Figure 22: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Software
Figure 23: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Software
Figure 24: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Reagents & Kits
Figure 25: North America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Reagents & Kits
Figure 26: North America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, , By Country
Figure 27: North America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Product
Figure 28: North America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application
Figure 29: North America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End User
Figure 30: Latin America Exosome Diagnostics and Therapeutic Market Share, By Product (2021)
Figure 31: Latin America Exosome Diagnostics and Therapeutic Market Share, By Application (2021)
Figure 32: Latin America Exosome Diagnostics and Therapeutic Market Share, By End User (2021)
Figure 33: Latin America Exosome Diagnostics and Therapeutic Market Share, By Country (2021)
Figure 34: Latin America Exosome Diagnostics and Therapeutic Market size (US$ Mn) 2021 & 2028
Figure 35: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021,
Figure 36: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 37: Brazil Exosome Diagnostic And Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 38: Brazil Exosome Diagnostic And Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 39: Mexico Exosome Diagnostic And Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 40: Mexico Exosome Diagnostic And Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 41: Rest of Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 42: Rest of Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 43: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Instruments
Figure 44: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Instruments
Figure 45: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Software
Figure 46: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Software
Figure 47: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Reagents & Kits
Figure 48: Latin America Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Reagents & Kits
Figure 49: Latin America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, , By Country
Figure 50: Latin America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Product
Figure 51: Latin America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application
Figure 52: Latin America Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End User
Figure 53: Western Europe Exosome Diagnostics and Therapeutic Market Share, By Product (2021)
Figure 54: Western Europe Exosome Diagnostics and Therapeutic Market Share, By Application (2021)
Figure 55: Western Europe Exosome Diagnostics and Therapeutic Market Share, By End User (2021)
Figure 56: Western Europe Exosome Diagnostics and Therapeutic Market Share, By Country (2021)
Figure 57: Western Europe Exosome Diagnostics and Therapeutic Market size (US$ Mn) 2021 & 2028
Figure 58: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021,
Figure 59: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 60: U.K Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 61: U.K Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 62: France Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 63: France Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 64: Germany Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 65: Germany Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 66: Italy Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 67: Italy Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 68: Spain Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 69: Spain Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 70: Rest of Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 71: Rest of Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 72: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Instruments
Figure 73: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Instruments
Figure 74: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Software
Figure 75: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Software
Figure 76: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Reagents & Kits
Figure 77: Western Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Reagents & Kits
Figure 78: Western Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, , By Country
Figure 79: Western Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Product
Figure 80: Western Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application
Figure 81: Western Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End User
Figure 82: Eastern Europe Exosome Diagnostics and Therapeutic Market Share, By Product (2021)
Figure 83: Eastern Europe Exosome Diagnostics and Therapeutic Market Share, By Application (2021)
Figure 84: Eastern Europe Exosome Diagnostics and Therapeutic Market Share, By End User (2021)
Figure 85: Eastern Europe Exosome Diagnostics and Therapeutic Market Share, By Country (2021)
Figure 86: Eastern Europe Exosome Diagnostics and Therapeutic Market size (US$ Mn) 2021 & 2028
Figure 87 Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021,
Figure 88: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 89: Russia Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 90: Russia Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 91: Poland Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 92: Poland Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 93: Rest of Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 94: Rest of Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 95: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Instruments
Figure 96: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Instruments
Figure 97: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Software
Figure 98: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Software
Figure 99: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Reagents & Kits
Figure 100: Eastern Europe Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Reagents & Kits
Figure 101: Eastern Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, , By Country
Figure 102: Eastern Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Product
Figure 103: Eastern Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application
Figure 104: Eastern Europe Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End User
Figure 105: APEJ Exosome Diagnostics and Therapeutic Market Share, By Product (2021)
Figure 106: APEJ Exosome Diagnostics and Therapeutic Market Share, By Application (2021)
Figure 107: APEJ Exosome Diagnostics and Therapeutic Market Share, By End User (2021)
Figure 108: APEJ Exosome Diagnostics and Therapeutic Market Share, By Country (2021)
Figure 109: APEJ Exosome Diagnostics and Therapeutic Market size (US$ Mn) 2021 & 2028
Figure 110: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021,
Figure 111: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 112: China Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 113: China Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 114: India Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 115: India Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 116: ASEAN Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 117: ASEAN Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 118: Australia and New Zealand Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 119: Australia and New Zealand Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 120: Rest of APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 121: Rest of APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 122: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Instruments
Figure 123: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Instruments
Figure 124: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Software
Figure 125: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Software
Figure 126: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Reagents & Kits
Figure 127: APEJ Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Reagents & Kits
Figure 128: APEJ Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, , By Country
Figure 129: APEJ Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Product
Figure 130: APEJ Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application
Figure 131: APEJ Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End User
Figure 132: Japan Exosome Diagnostics and Therapeutic Market Share, By Product (2021)
Figure 133: Japan Exosome Diagnostics and Therapeutic Market Share, By Application (2021)
Figure 134: Japan Exosome Diagnostics and Therapeutic Market Share, By End User (2021)
Figure 135: Japan Exosome Diagnostics and Therapeutic Market size (US$ Mn) 2021 & 2028
Figure 136: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Instruments
Figure 137: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Instruments
Figure 138: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Software
Figure 139: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Software
Figure 140: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Reagents & Kits
Figure 141: Japan Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Reagents & Kits
Figure 142: Japan Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Product
Figure 143: Japan Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application
Figure 144: Japan Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End User
Figure 145: MEA Exosome Diagnostics and Therapeutic Market Share, By Product (2021)
Figure 146: MEA Exosome Diagnostics and Therapeutic Market Share, By Application (2021)
Figure 147: MEA Exosome Diagnostics and Therapeutic Market Share, By End User (2021)
Figure 148: MEA Exosome Diagnostics and Therapeutic Market Share, By Country (2021)
Figure 149: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021,
Figure 150: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 151: GCC Countries Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 152: GCC Countries Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 153: South Africa Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021
Figure 154: South Africa Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 155: Rest of MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Country
Figure 156: Rest of MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 157: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Instruments
Figure 158: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Instruments
Figure 159: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Software
Figure 160: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Software
Figure 161: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) Analysis, 2012–2021, By Reagents & Kits
Figure 162: MEA Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028, By Reagents & Kits
Figure 163: MEA Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, , By Country
Figure 164: MEA Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Product
Figure 165: MEA Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application
Figure 166: MEA Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End User
Figure 167: Exosome Diagnostics Inc. Number of Pipeline Products by Category (2021)
Figure 168: Exosome Diagnostic Inc. Pipeline Analysis By Geography (2021)
Figure 169: Exosome Diagnostics Inc. Number of Pipeline Products by Development Stage (2021)
Figure 170: Exosome Diagnostics Inc. Number of Pipeline Products by Indication (2021
Figure 171: Exiqon AS Pipeline Analysis By Development Status (2021)
Figure 172: Exiqon AS Pipeline Analysis By Indication
Figure 173: Miltenyi Biotec GmbH Pipeline Analysis By Development Status (2021)
Figure 174: Miltenyi Biotec GmbH Pipeline Analysis By Indication
Figure 175: Global Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Region
Figure 176: Global Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Product
Figure 177: Global Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By Application
Figure 178: Global Exosome Diagnostic and Therapeutic Market Attractiveness Analysis, By End User
Figure 179: Global Single-Photon Emission Computed Tomography Historical Market Size and Y-o-Y, 2012 - 2021
Figure 180: Global Exosome Diagnostic and Therapeutic Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028
Figure 181: Global Exosome Diagnostic and Therapeutic Market Absolute $ Opportunity, 2012–2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
